T. BARLAS Et Al. , "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy," EndoBridge 2023 , Turkey, 2023
BARLAS, T. Et Al. 2023. Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy. EndoBridge 2023 , (Turkey).
BARLAS, T., KAYHAN, G., YALÇIN, M. M., CERİT, E. T., AKTÜRK, M. Y., TÖRÜNER, F. S., ... SÖZEN, T. S.(2023). Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy . EndoBridge 2023, Turkey
BARLAS, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy," EndoBridge 2023, Turkey, 2023
BARLAS, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy." EndoBridge 2023 , Turkey, 2023
BARLAS, T. Et Al. (2023) . "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy." EndoBridge 2023 , Turkey.
@conferencepaper{conferencepaper, author={TUĞBA BARLAS Et Al. }, title={Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushing's syndrome and the vanishing effect of octreotide therapy}, congress name={EndoBridge 2023}, city={}, country={Turkey}, year={2023}}